Luca Trotta will lead a highly talented and multi-cultural scientific team in the newly opened Lugano branch

Lugano, March 2021 – Luca Trotta, Ph.D. in genetics, medical geneticist and scientific advisor, with his long-standing international experience in genomics, joined GenomSys as Chief Scientific Officer. Simultaneously, GenomSys opened a new office in Lugano to tap into the vibrant innovation scene in Ticino and to accelerate the company's growth.

“I joined GenomSys because their disruptive view of personalized medicine aligns perfectly with what I envision. Smart and simple personalized applications can enable everyone to easily access, control, and share their own health information. This would resolve privacy issues and remove the technical limits to individual contribution to continuous research”, says Luca “In my vision, there is no ‘personal’ without community, therefore everyone must have the right to access the most personalized healthcare possible, which evidently can only result from meaningful research efforts.”

Luca’s core experience is the clinical interpretation of genomic variation and the implementation of genomic analyses workflows, particularly in Whole-Exome Sequencing (WES). For 10+ years he focused on the diagnostic of rare inherited disorders, immunology, and oncology, first at the Molecular Genetic Unit of the Policlinico Hospital in Milan and then at the Institute for Molecular Medicine Finland (FIMM) in Helsinki. During his time in Finland, he successfully postulated his Ph.D. thesis demonstrating the capacity of WES as diagnostic tool for primary immunodeficiencies. After his Ph.D., he embraced the entrepreneurial challenge to grow small genomic testing companies in Switzerland before joining GenomSys.

Regarding genetics and personalized medicine, Luca says: “I have been fortunate to witness the whirling advance of genetics from the inside over the last 20 years. When I started, the words genomics and personalized medicine were still far to be heard, now genetics is a powerful instrument to aid in many aspects of everyday life. But the growing amount of knowledge brings new challenges: How can we get the most out of genomics from a personal perspective?”

Luca’s expertise will provide GenomSys with deeper insights into genetics. His contribution is key to pursue the company vision, i.e., to enable personalized medicine for everyone in the most convenient way, with the utmost respect for individuals’ privacy. The innovative MPEG-G-compliant solutions for data analysis, featuring native encryption, selective access, and high compression rate, will enable higher efficiency in genetic testing. In his role of Chief Scientific Officer Luca leads GenomSys scientific team, composed of talented bioinformaticians and a panel of top-notch scientific advisors.

Read full press release